Viking Therapeutics Inc [NASDAQ: VKTX] stock went on an upward path that rose over 11.31% on Wednesday, amounting to a one-week price increase of more than 4.70%.
Over the last 12 months, VKTX stock rose by 285.49%. The one-year Viking Therapeutics Inc stock forecast points to a potential upside of 45.07. The average equity rating for VKTX stock is currently 1.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $6.74 billion, with 110.80 million shares outstanding and 103.61 million shares in the current float. Compared to the average trading volume of 3.80M shares, VKTX stock reached a trading volume of 5546991 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Viking Therapeutics Inc [VKTX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VKTX shares is $110.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VKTX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JP Morgan have made an estimate for Viking Therapeutics Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on Sep-12-24. While these analysts kept the previous recommendation, Morgan Stanley raised their target price to Overweight. The new note on the price target was released on June 27, 2024, representing the official price target for Viking Therapeutics Inc stock. Previously, the target price had yet another raise from $115 to $116, while Raymond James kept a Strong Buy rating on VKTX stock. On March 26, 2024, analysts increased their price target for VKTX shares from 116 to 138.
The Average True Range (ATR) for Viking Therapeutics Inc is set at 4.30 The Price to Book ratio for the last quarter was 7.32, with the Price to Cash per share for the same quarter was set at 8.50.
VKTX Stock Performance Analysis:
Viking Therapeutics Inc [VKTX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.70. With this latest performance, VKTX shares gained by 4.18% in over the last four-week period, additionally sinking by -9.34% over the last 6 months – not to mention a rise of 285.49% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VKTX stock in for the last two-week period is set at 53.84, with the RSI for the last a single of trading hit 56.04, and the three-weeks RSI is set at 52.84 for Viking Therapeutics Inc [VKTX]. The present Moving Average for the last 50 days of trading for this stock 57.19, while it was recorded at 55.96 for the last single week of trading, and 50.90 for the last 200 days.
Insight into Viking Therapeutics Inc Fundamentals:
Viking Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 37.69 and a Current Ratio set at 37.69.
VKTX Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VKTX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Viking Therapeutics Inc go to 40.00%.
Viking Therapeutics Inc [VKTX] Institutonal Ownership Details
There are presently around $75.20%, or 80.07%% of VKTX stock, in the hands of institutional investors. The top three institutional holders of VKTX stocks are: FMR LLC with ownership of 16.54 million shares, which is approximately 15.9876%. VANGUARD GROUP INC, holding 10.1 million shares of the stock with an approximate value of $$535.26 million in VKTX stocks shares; and VANGUARD GROUP INC, currently with $$319.45 million in VKTX stock with ownership which is approximately 5.8248%.
